首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備呼吸器

市場調查報告書

商品編碼

1477313

數位劑量吸入器市場，依產品（定量吸入器、乾粉吸入器等）、依類型、依適應症、依最終用戶、依地理位置

Digital Dose Inhaler Market, By Product (Metered Dose Inhaler, Dry Powder Inhaler, Others), By Type, By Indication, By End User, By Geography

出版日期: 2024年04月11日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球數位劑量吸入器市值為183.3億美元，預計2031年將達到643.3億美元，2024年至2031年的年複合成長率（CAGR）為19.6%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	183.3 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	19.60%	2031 年價值預測：	643.3 億美元

數字。數位劑量吸入器市場佔有率 (%)，依地區 2024 年

數位劑量吸入器是一種攜帶式手持設備，用於輸送藥物以治療哮喘和慢性阻塞性肺病等呼吸系統疾病。這些設備可偵測吸氣並以空氣霧化形式釋放精確劑量的藥物以供吸入。與傳統的加壓計量吸入器和乾粉吸入器相比，數位劑量吸入器具有多種優點。它們配備了感測器，可以自動追蹤藥物使用情況，並透過藍牙將資料傳輸到配套應用程式。這使得醫生能夠進行遠端監控並確保用藥依從性。連接的功能還允許吸入器向患者提供回饋和提醒。數位劑量吸入器旨在透過個人化治療、嚴格的依從性監測以及與數位健康解決方案的整合來改善呼吸系統患者的治療結果。

市場動態：

全球數位劑量吸入器市場的成長是由全球呼吸系統疾病盛行率不斷上升、對藥物依從性的日益關注、政府對呼吸系統疾病管理的有利舉措以及對互聯數位健康解決方案的認知不斷提高推動的。然而，與傳統吸入器相比，數位吸入器的開發和製造成本較高，可能會阻礙市場成長。一些國家缺乏數位治療設備的報銷政策也阻礙了其採用。持續的技術進步、網際網路和智慧型手機普及率的提高、數位吸入器的應用範圍擴大到呼吸系統疾病以外的領域，為市場參與者提供了巨大的成長機會。

研究的主要特點：

該報告對全球數位劑量吸入器市場進行了深入分析，並提供了預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%），以2023年為基準年。
它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球數位劑量吸入器市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球數位劑量吸入器市場迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球數位劑量吸入器市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 10 章：競爭格局

公司簡介
- 3M
- AstraZeneca
- GLENMARK PHARMACEUTICALS LTD.
- Novartis AG
- Sensirion AG
- Propeller Health
- OPKO Health, Inc.
- Teva Pharmaceutical Industries Ltd.
- BEXIMCO Pharmaceuticals
- GSK plc.
- Mundhipharma International
- Honeywell International Inc.
- Veranex
- Cognita Labs

第 11 章：分析師建議

命運之輪
分析師觀點
連貫的機會圖

第 12 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6889

Global digital dose inhaler market is estimated to be valued at USD 18.33 Bn in 2024 and is expected to reach USD 64.33 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 19.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 18.33 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	19.60%	2031 Value Projection:	US$ 64.33 Bn

Figure. Digital Dose Inhaler Market Share (%), By Region 2024

Digital dose inhalers are portable handheld devices that are used for delivering medication to treat respiratory diseases like asthma and COPD. These devices detect inspiration and release an exact dose of medication in the air aerosolized form for inhalation. Digital dose inhalers offer several advantages over conventional pressurized metered dose inhalers and dry powder inhalers. These are equipped with sensors that can track medication use automatically and transmit the data via Bluetooth to a companion app. This enables remote monitoring by physicians and ensures medication adherence. The connected features also allow the inhalers to provide feedback and reminders to patients. Digital dose inhalers aim to improve treatment outcomes for respiratory patients through personalized therapies, strict adherence monitoring, and integration with digital health solutions.

Market Dynamics:

Global digital dose inhaler market growth is driven by growing prevalence of respiratory diseases globally, increasing focus on medication adherence, favorable government initiatives for respiratory disease management, and rising awareness about connected digital health solutions. However, the market growth can be hampered by high costs associated with developing and manufacturing digital inhalers as compared to conventional inhalers. Lack of reimbursement policies for digital therapeutic devices in some countries also hampers its adoption. Continual technological advancements, increasing internet and smartphone penetration, expanding applications of digital inhalers beyond respiratory diseases present significant growth opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global digital dose inhaler market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global digital dose inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes 3M, AstraZeneca, GLENMARK PHARMACEUTICALS LTD., Novartis AG, Sensirion AG, Propeller Health, OPKO Health, Inc., Teva Pharmaceutical Industries Ltd., BEXIMCO Pharmaceuticals, GSK plc., Mundhipharma International, Honeywell International Inc., Veranex and Cognita Labs
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global digital dose inhaler market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital dose inhaler market

Detailed Segmentation-

Product:
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
- Others
Type:
- Branded
- Generic
Indication:
- Asthma
- COPD
- Others
End User:
- Hospitals
- Homecare Settings
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- 3M
- AstraZeneca
- GLENMARK PHARMACEUTICALS LTD.
- Novartis AG
- Sensirion AG
- Propeller Health
- OPKO Health, Inc.
- Teva Pharmaceutical Industries Ltd.
- BEXIMCO Pharmaceuticals
- GSK plc.
- Mundhipharma International
- Honeywell International Inc.
- Veranex
- Cognita Labs

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Type
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Fundings and Investments
PEST Analysis
Porter's Analysis

4. Global Digital Dose Inhaler Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Digital Dose Inhaler Market, By Product, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Metered Dose Inhaler (MDI)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Dry Powder Inhaler (DPI)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Digital Dose Inhaler Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Generic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Digital Dose Inhaler Market, By Indication, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Asthma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
COPD
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Digital Dose Inhaler Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Homecare Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Digital Dose Inhaler Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
North Africa
Central Africa
South Africa